SARS-CoV-2 and the pandemic of COVID-19

@article{Adil2020SARSCoV2AT,
  title={SARS-CoV-2 and the pandemic of COVID-19},
  author={Md Tanveer Adil and Rumana Rahman and Douglas E Whitelaw and Vigyan Jain and Omer S Al-Taan and Farhan Rashid and Aruna Munasinghe and Periyathambi Jambulingam},
  journal={Postgraduate Medical Journal},
  year={2020},
  volume={97},
  pages={110 - 116}
}
SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30, 2020, a total of 5 899 866 positive cases were registered including 364 891 deaths. SARS-CoV-2 primarily targets the lung and enters the body through ACE2 receptors. Typical symptoms of COVID-19… 

A single BNT162b2 dose protects against SARS-CoV-2: A case report of a family cluster of COVID-19.

TLDR
This is the first case report of the protective effect of single BNT162b2 vaccine dose in the context of high transmission rates within a family nucleus, and despite changes induced by BNT 162b2 in the antibody titers with single or double dose vaccination, a single dose showed to be sufficient for immunization of patients against COVID-19.

Influence of the COVID-19 pandemic on the incidence of tuberculosis and influenza

TLDR
The increased motivation of the population to protect their health during the COVID-19 pandemic provided an opportunity for their effective education and could have hindered TB infections more than the two viral diseases, which appear to be more contagious.

SARS-CoV-2 and the Missing Link of Intermediate Hosts in Viral Emergence - What We Can Learn From Other Betacoronaviruses

TLDR
Historic context regarding the roles of reservoir and intermediate hosts in coronavirus circulation is provided and current knowledge of these for SARS-CoV-2 is discussed to help control the global health and economic impacts of COVID-19.

SARS-CoV-2 Is Persistent in Placenta and Causes Macroscopic, Histopathological, and Ultrastructural Changes

TLDR
The clinical history of five pregnant women infected with SARS-CoV-2 (four symptomatic and one asymptomatic who gave birth to a stillborn child) during the COVID-19 pandemic is reported to contribute to a better understanding of the consequences of Sars-Cov-2 infection in placental tissue, vertical transmission.

The Impact of COVID-19 Vaccine on Rate of Hospitalization and Outcome of COVID- 19 Infection in a Single Center in the Eastern Province of Saudi Arabia

TLDR
The majority of the study participants didn’t receive any vaccines before their admission with COVID 19, which in turn prolonged their hospital stay, which necessitates that the public require more awareness regarding the importance of receiving the vaccine.

A Case-Control Study for the Effectiveness of Oral Zinc in the Prevention and Mitigation of COVID-19

TLDR
It is suggested that zinc supplementation in all three doses (10, 25, and 50 mg) may be an effective prophylaxis of symptomatic COVID-19 and may mitigate the severity of CO VID-19 infection.

Neurological manifestations associated with COVID- 19: a review

TLDR
Given existing knowledge of other coronaviruses and respiratory viruses, the wide range of CNS and PNS associations with COVID-19 is not surprising, and this is the focus of most current reports.

2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update

TLDR
The development process, synthesis, mechanism of viral eradication, and preclinical and clinical development of 2-DG and its derivatives as molecularly targeted therapeutics for COVID-19 treatment are described.

Do the Successive Waves of SARS-CoV-2, Vaccination Status and Place of Infection Influence the Clinical Picture and COVID-19 Severity among Patients with Persistent Clinical Symptoms? The Retrospective Study of Patients from the STOP-COVID Registry of the PoLoCOV-Study

TLDR
The persistence of the pandemic has resulted in significant changes observed in the clinical picture, with vaccinated individuals reported less taste and/or olfactory dysfunction than unvaccinated individuals.
...

References

SHOWING 1-10 OF 59 REFERENCES

The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

TLDR
It remains to make clear whether the potential invasion of SARS‐CoV2 is partially responsible for the acute respiratory failure of patients with COVID‐19, which emerged in December 2019 in Wuhan, China and rapidly spreads around the world.

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TLDR
Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

TLDR
In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status, and these observations require evaluation in clinical trials.

Why tocilizumab could be an effective treatment for severe COVID-19?

TLDR
It is suggested that Tocilizumab is an effective treatment in severe patients of COVID-19 to calm the inflammatory storm and reduce mortality.

A new coronavirus associated with human respiratory disease in China

TLDR
Phylogenetic and metagenomic analyses of the complete viral genome of a new coronavirus from the family Coronaviridae reveal that the virus is closely related to a group of SARS-like coronaviruses found in bats in China.

The proximal origin of SARS-CoV-2

TLDR
It is shown that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus, and scenarios by which they could have arisen are discussed.

Remdesivir for the Treatment of Covid-19 — Final Report

TLDR
The data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection.

Clinical Characteristics of Coronavirus Disease 2019 in China

TLDR
During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

TLDR
In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir–ritonavir treatment beyond standard care, and future trials in patients withsevere illness may help to confirm or exclude the possibility of a treatment benefit.
...